Citigroup’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-932
Closed -$499 5125
2024
Q4
$499 Sell
932
-374
-29% -$200 ﹤0.01% 4755
2024
Q3
$2.3K Sell
1,306
-55,262
-98% -$97.2K ﹤0.01% 4588
2024
Q2
$66.2K Buy
56,568
+42,856
+313% +$50.1K ﹤0.01% 3703
2024
Q1
$124K Buy
13,712
+5,525
+67% +$49.9K ﹤0.01% 3477
2023
Q4
$89K Buy
8,187
+7,532
+1,150% +$81.9K ﹤0.01% 3504
2023
Q3
$5.27K Sell
655
-15,041
-96% -$121K ﹤0.01% 3979
2023
Q2
$170K Sell
15,696
-89,590
-85% -$973K ﹤0.01% 3300
2023
Q1
$726K Buy
105,286
+29,483
+39% +$203K ﹤0.01% 2256
2022
Q4
$302K Buy
75,803
+67,299
+791% +$268K ﹤0.01% 2832
2022
Q3
$57K Buy
8,504
+7,064
+491% +$47.3K ﹤0.01% 3626
2022
Q2
$7K Sell
1,440
-1,540
-52% -$7.49K ﹤0.01% 4761
2022
Q1
$28K Sell
2,980
-8,260
-73% -$77.6K ﹤0.01% 4263
2021
Q4
$134K Sell
11,240
-5,623
-33% -$67K ﹤0.01% 3818
2021
Q3
$192K Buy
16,863
+11,234
+200% +$128K ﹤0.01% 3400
2021
Q2
$101K Buy
5,629
+1,390
+33% +$24.9K ﹤0.01% 3850
2021
Q1
$65K Sell
4,239
-5,282
-55% -$81K ﹤0.01% 3908
2020
Q4
$116K Buy
9,521
+8,320
+693% +$101K ﹤0.01% 3587
2020
Q3
$15K Sell
1,201
-1,707
-59% -$21.3K ﹤0.01% 4118
2020
Q2
$30K Sell
2,908
-3,048
-51% -$31.4K ﹤0.01% 4013
2020
Q1
$48K Buy
5,956
+3,378
+131% +$27.2K ﹤0.01% 3809
2019
Q4
$22K Buy
2,578
+1,135
+79% +$9.69K ﹤0.01% 4467
2019
Q3
$9K Sell
1,443
-2,072
-59% -$12.9K ﹤0.01% 4628
2019
Q2
$59K Buy
3,515
+211
+6% +$3.54K ﹤0.01% 3969
2019
Q1
$55K Buy
3,304
+916
+38% +$15.2K ﹤0.01% 3968
2018
Q4
$28K Buy
2,388
+166
+7% +$1.95K ﹤0.01% 4269
2018
Q3
$89K Buy
2,222
+1,209
+119% +$48.4K ﹤0.01% 3678
2018
Q2
$29K Buy
1,013
+968
+2,151% +$27.7K ﹤0.01% 4226
2018
Q1
$1K Sell
45
-274
-86% -$6.09K ﹤0.01% 4861
2017
Q4
$10K Buy
+319
New +$10K ﹤0.01% 4516
2015
Q4
Sell
-6
Closed 5711
2015
Q3
$0 Sell
6
-8
-57% ﹤0.01% 5594
2015
Q2
$1K Buy
+14
New +$1K ﹤0.01% 5388